Hashimoto's thyroiditis is the most common autoimmune condition we see in practice, and it's consistently undertreated. Not because the thyroid piece is complicated. The standard of care (levothyroxine, or a T4/T3 combination) does a reasonable job of normalizing labs. The problem is that many patients normalize their labs and still feel terrible. Fatigue, brain fog, hair that keeps falling out, weight that won't move, a low-grade depression that medication doesn't touch. At that point, most practitioners shrug and say the numbers look fine.
The numbers don't tell the whole story. Hashimoto's is an immune system problem that happens to target the thyroid. Managing it only at the thyroid level is like pulling out the smoke detector because it keeps going off. The fire is still in the gut.
Why the Gut Is Involved
People with Hashimoto's have a significantly higher rate of Non-Celiac Gluten Sensitivity (NCGS) and Celiac disease than the general population. We see this consistently in practice, and the research supports it. These aren't just two conditions that happen to share a patient. They share mechanisms.
Celiac disease is an autoimmune reaction to gluten that produces measurable antibodies (anti-gliadin, anti-tissue transglutaminase, anti-endomysium) and causes damage to the intestinal lining you can confirm on biopsy. NCGS is the clinical diagnosis when someone reacts to gluten (GI symptoms, fatigue, brain fog, joint pain) without the antibody profile or intestinal damage that defines celiac. NCGS is harder to pin down in a lab but clinically real and clinically significant. In Hashimoto's, both matter.
The Mechanisms Behind the Overlap
The HLA-DQ2 and HLA-DQ8 genes are the primary genetic markers for Celiac disease, and these same variants appear at higher frequencies in Hashimoto's patients. That's not coincidence. It's a shared susceptibility to immune dysregulation when exposed to the same triggers.
Gliadin, a protein fraction of gluten, also has structural similarities to thyroid peroxidase (TPO). The immune system, already mounted against one, can cross-react against the other. This is one of the mechanisms by which an autoimmune response in one tissue system spreads to another, and it's why autoimmune diseases cluster: Hashimoto's patients have elevated rates of rheumatoid arthritis, lupus, and type 1 diabetes too.
Then there's intestinal permeability. Both Hashimoto's and gluten sensitivity cause increased permeability in the gut lining (what most people have heard called "leaky gut"). When the gut barrier loses integrity, partially digested food proteins and bacterial components cross into the bloodstream. The immune system responds to them as threats. Some of those immune responses generate antibodies. Some of those antibodies cross-react with thyroid tissue. The thyroid inflammation drives more systemic immune activity, which worsens gut permeability, which perpetuates the cycle. Replacing thyroid hormone doesn't interrupt this loop at all.
Both conditions also share the same immune skew: an overactive Th1/Th17 response. That's the arm of the immune system that drives autoimmunity. When one pathway is active, the threshold for triggering another is lower.
What We Watch In Practice
The marker we follow closely is TPO antibodies. Normalizing TSH and T4 is necessary but not sufficient when TPO antibodies remain significantly elevated and the patient still feels bad. Elevated antibodies mean the immune attack on the thyroid is ongoing. Replacing the hormone compensates for the damage. It doesn't stop the attack.
A gluten-free diet can lower TPO antibodies. Multiple studies have demonstrated this, and there is currently an active clinical trial (NCT07060118) studying exactly this question: whether a strict gluten-free diet improves symptoms and quality of life in Hashimoto's patients who are on adequate thyroid hormone replacement but remain symptomatic, with elevated antibodies. The trial required participants to have TPO antibodies above 500 IU/mL or anti-thyroglobulin above 50 IU/mL, alongside a documented quality-of-life score reflecting significant impairment. That describes a substantial portion of Hashimoto's patients who have been told there's nothing more to do.
A note on what "adequate" thyroid hormone means
Normalized TSH alone isn't the full picture. Some patients need Free T3 and Free T4 in the upper portion of the reference range to feel well. Some convert T4 to T3 poorly and do better on a combination medication. Labs that look "normal" by standard reference ranges are not always optimal for that individual. This matters before concluding that the thyroid piece is fully managed.
What We Do
We don't put every Hashimoto's patient on a gluten-free diet automatically. But if someone isn't feeling well on optimized thyroid hormone, if their TPO antibodies are significantly elevated, or if they have any GI symptoms, even ones they've normalized and stopped mentioning, gluten is one of the first things we remove.
Before we start, we run antibody testing: anti-gliadin IgG and IgA, tissue transglutaminase IgA, and ideally an IgG food sensitivity panel. We document baseline TPO and anti-thyroglobulin antibody levels. Then we do a strict four-week elimination. Strict is the operative word. Even small amounts of gluten maintain the immune response. Cross-contamination counts. This isn't a "mostly gluten-free" experiment.
At four weeks, we reintroduce gluten and watch what happens. Most people know fairly quickly whether it was a factor. The ones where it is typically report better energy, less brain fog, improved sleep, and often GI symptoms they didn't realize had been off because they'd stopped attributing them to anything. Then we recheck antibodies at six months.
Sometimes the numbers move significantly. TPO drops by hundreds of IU/mL. That's not a placebo response. That's an immune system that's no longer being triggered by something it was cross-reacting against. When that happens, the clinical picture usually shifts too: better labs, better symptoms, less inflammation to manage downstream.
If the connection between Hashimoto's and gluten were a fringe theory, we'd treat it that way. It isn't. The genetic overlap, the shared immune pathways, the intestinal permeability loop, the antibody cross-reactivity, and now an active clinical trial specifically designed to measure the therapeutic effect of gluten removal in this population. The evidence is solid enough to act on. If your Hashimoto's isn't responding the way it should, the immune driver deserves as much attention as the thyroid replacement dose.